Conflict of Interest
M.C. is a clinical consultant and has stock ownership in the GID Bio Group. S.M. declared an advisory role with Chinook Therapeutics, received honoraria from Bayer, Otsuka, Alexion, and research funding from Horizon. I.P. declared leadership position with MD Radiology. D.C. is a full-time employee of IQVIA. All of the other authors declared no potential conflicts of interest.